LILLY ENDOWMENT INCLILLY ENDOWMENT INC

Institutional investor · Portfolio as of Q4 2024

SEC EDGAR SourceSEC Filings
$74.8B
AUM
1
Positions
Q4 2024
Filing
Rating · 1.5
Quarterly Portfolio Change
Not enough history yet
Activity profile
$ moved · Q4'24
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 5.8 years
<1Q0%1-4Q0%1-2Y0%2Y+100%

LILLY ENDOWMENT INC manages $74.8B across 1 positions as of Q4 2024. Top holdings: LLY (100.0%). Fund DNA: Concentrated Value. HoldingsIntel Rating: 1.5/5.0.

Q4 2024 Summary

Held steady with 1 unchanged positions. No standout high-conviction moves this quarter. Portfolio: $74.8B across 1 positions.

Top holdings by portfolio weight

Total AUM$75B
LLY100.00%

Portfolio allocation by GICS sector

Sectors1
Healthcare100.00%

Behavioral investing profile

Concentrated Value67%- primarily Healthcare
Compare DNA across all funds
7-dimension quality assessment
Below Average(1.5 / 5.0)
Track Record0
Conviction34
Concentration0
Upgrade to see all dimensions

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Holdings1 positions

Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

ELI LILLY & CO

96.9M$74.8B100.0%$118.50+547.11%
24 qtrssince 2019-Q1
Unchanged
0

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used